Biogen CEO Michel Vounatsos On Approval Of Alzheimer’s Drug

Biogen CEO Michel Vounatsos

First on CNBC: CNBC Transcript: Biogen Inc (NASDAQ:BIIB) CEO Michel Vounatsos Speaks with CNBC’s “Power Lunch” today, discussing FDA’s approval of its Alzheimer’s drug. Q1 2021 hedge fund letters, conferences and more WHEN: Today, Monday, June 7th WHERE: CNBC’s “Power Lunch” Biogen CEO On FDA Approval For Its Alzheimer’s Drug All references must be sourced […]

The post Biogen CEO Michel Vounatsos On Approval Of Alzheimer’s Drug appeared first on ValueWalk.

Jump To The Original Source

Share this Story
Load More Related Articles
Load More In Investing

Facebook Comments

Check Also

US Navy tests warship’s metal with megablast

Published by AFP Miami (AFP) – The US ...

Archives